IMDX - Oncocyte Corp

QQQ $ 612.11 $ 7.61 (1.26 %)

DIA $ 467.12 $ 5.24 (1.13 %)

SPY $ 671.75 $ 6.91 (1.04 %)

TLT $ 91.68 $ 0.35 (0.38 %)

GLD $ 401.36 $ 14.16 (3.64 %)

Previous Close

$ 5.89

Open

$ 5.30

Bid

$ 4.06 x 1,000

Ask

$ 7.03 x 200

Day's Range

$ 5.24 - $ 6.08

52 Week Range

$ 1.92 - $ 6.08

Volume

131,481

Average Volume

Market Cap

168.57M

Beta (5Y Monthly)

$ 1.00

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-11-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	03-24-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-15-2024	03-31-2024	10-Q
7	04-16-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-10-2023	06-30-2023	10-Q
10	05-15-2023	03-31-2023	10-Q
11	04-12-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-12-2022	03-31-2022	10-Q
15	03-11-2022	12-31-2021	10-K
16	11-09-2021	09-30-2021	10-Q
17	08-11-2021	06-30-2021	10-Q
18	05-17-2021	03-31-2021	10-Q
19	03-19-2021	12-31-2020	10-K
20	11-12-2020	09-30-2020	10-Q
21	07-29-2020	06-30-2020	10-Q
22	05-12-2020	03-31-2020	10-Q
23	03-26-2020	12-31-2019	10-K
24	11-14-2019	09-30-2019	10-Q
25	08-14-2019	06-30-2019	10-Q
26	05-14-2019	03-31-2019	10-Q
27	04-01-2019	12-31-2018	10-K
28	11-13-2018	09-30-2018	10-Q
29	08-14-2018	06-30-2018	10-Q
30	05-15-2018	03-31-2018	10-Q
31	04-02-2018	12-31-2017	10-K
32	11-14-2017	09-30-2017	10-Q
33	08-14-2017	06-30-2017	10-Q
34	04-28-2017	03-31-2017	10-Q
35	02-27-2017	12-31-2016	10-K
36	11-10-2016	09-30-2016	10-Q
37	08-11-2016	06-30-2016	10-Q
38	05-16-2016	03-31-2016	10-Q
39	03-30-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Insight Molecular Diagnostics Publishes Gr...
10/06/2025 11:20:01

American Journal of Transplantation study positions GraftAssure as potentially essential in managing immunosuppression treatmen...

Insight Molecular Launches 5,000-Patient R...
09/08/2025 11:16:35

Insight Molecular Diagnostics, Inc. (NASDAQ:IMDX), ("iMDx"), today announced a positive strategic update and novel regi...

Insight Molecular Diagnostics Enrolls Pati...
09/08/2025 11:07:25

iMDx's ClinicalTrials.gov listing now names 10 leading transplant centers, up from 5 previouslyGraftAssureDx remains on tra...

12 Health Care Stocks Moving In Tuesday's ...
08/19/2025 21:06:03

Needham Reiterates Buy on Insight Molecula...
08/18/2025 09:59:16

Needham analyst Mike Matson reiterates Insight Molecular (NASDAQ:IMDX) with a Buy and maintains $4.25 price target.

Insight Molecular Q2 EPS $(0.30) Misses $(...
08/11/2025 20:06:44

Insight Molecular (NASDAQ:IMDX) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $...

Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

Exploring Insight Molecular's Earnings Exp...
08/08/2025 20:04:16

Insight Molecular Diagnostics To Present T...
07/30/2025 20:28:03

iMDx first dd-PCR assay to combine relative and absolute measurements of dd-cfDNA into single combined scoreData show significa...

12 Health Care Stocks Moving In Friday's A...
07/25/2025 21:06:49

iMDx Reports Results From Study Evaluating...
06/23/2025 20:06:20

Study indicates iMDx flagship technology's equivalence with commercially available dd-cfDNA test kitsHead-to-head compariso...

12 Health Care Stocks Moving In Friday's A...
06/20/2025 21:05:49

12 Health Care Stocks Moving In Friday's P...
06/20/2025 12:09:39